Abstract
Recent work aimed at the introduction of natural and synthetic cannabinoids as drugs is reviewed. Delta1-Tetrahydrocannabinol (delta1-THC) is mainly investigated as a potential drug against glaucoma and asthma, and as an antiemetic agent in cancer chemotherapy. Cannabidiol is being tried in the clinic against epilepsy and as a hypnotic. Numerous synthetic cannabinoids are currently being investigated as analgetics and as sedative-relaxants.
Publication types
-
Historical Article
-
Review
MeSH terms
-
Analgesics
-
Anti-Inflammatory Agents
-
Antiemetics
-
Asthma / drug therapy
-
Cannabidiol / therapeutic use
-
Cannabinoids / therapeutic use
-
Cannabis*
-
Dronabinol / therapeutic use
-
Dronabinol / toxicity
-
Epilepsy / drug therapy
-
Glaucoma / drug therapy
-
History, Ancient
-
History, Medieval
-
History, Modern 1601-
-
Humans
-
Hypertension / drug therapy
-
Medicine, Arabic
-
Medicine, East Asian Traditional
-
Phytotherapy
-
Sleep Initiation and Maintenance Disorders / drug therapy
-
Structure-Activity Relationship
Substances
-
Analgesics
-
Anti-Inflammatory Agents
-
Antiemetics
-
Cannabinoids
-
Cannabidiol
-
Dronabinol